<SEC-DOCUMENT>0001641172-25-024036.txt : 20250814
<SEC-HEADER>0001641172-25-024036.hdr.sgml : 20250814
<ACCEPTANCE-DATETIME>20250814161550
ACCESSION NUMBER:		0001641172-25-024036
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250814
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250814
DATE AS OF CHANGE:		20250814

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			bioAffinity Technologies, Inc.
		CENTRAL INDEX KEY:			0001712762
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				465211056
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41463
		FILM NUMBER:		251219359

	BUSINESS ADDRESS:	
		STREET 1:		3300 NACOGDOCHES ROAD
		STREET 2:		SUITE 216
		CITY:			SAN ANTONIO
		STATE:			TX
		ZIP:			78217
		BUSINESS PHONE:		210-698-5334

	MAIL ADDRESS:	
		STREET 1:		3300 NACOGDOCHES ROAD
		STREET 2:		SUITE 216
		CITY:			SAN ANTONIO
		STATE:			TX
		ZIP:			78217
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:BIAF="http://bioaffinitytech.com/20250814">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_03C_BIAF_bioaffinitytech.com_20250814 -->
<!-- Field: Set; Name: xdx; ID: xdx_04E_20250814_20250814 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DEntityCentralIndexKey_0001712762 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-08-14" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-08-14" id="Fact000004" name="dei:EntityCentralIndexKey">0001712762</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="biaf-20250814.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-08-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001712762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-08-14</xbrli:startDate>
        <xbrli:endDate>2025-08-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-08-142025-08-14_custom_CommonStockParValue.007PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001712762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BIAF:CommonStockParValue.007PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-08-14</xbrli:startDate>
        <xbrli:endDate>2025-08-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-08-142025-08-14_custom_TradeableWarrantsToPurchaseCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001712762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BIAF:TradeableWarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-08-14</xbrli:startDate>
        <xbrli:endDate>2025-08-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_904_edei--DocumentType_c20250814__20250814_zxGp6jsgIVJ5"><ix:nonNumeric contextRef="AsOf2025-08-14" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <b><span id="xdx_90A_edei--DocumentPeriodEndDate_c20250814__20250814_zkWz7gvqtfLe"><ix:nonNumeric contextRef="AsOf2025-08-14" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">August
14, 2025</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span id="xdx_90B_edei--EntityRegistrantName_c20250814__20250814_zNZBXAP5DUk6" style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><ix:nonNumeric contextRef="AsOf2025-08-14" id="Fact000011" name="dei:EntityRegistrantName">BIOAFFINITY
TECHNOLOGIES, INC.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityIncorporationStateCountryCode_c20250814__20250814_zVLCs2xxFDMd"><ix:nonNumeric contextRef="AsOf2025-08-14" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span id="xdx_904_edei--EntityFileNumber_c20250814__20250814_zh1N1m5vCduh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2025-08-14" id="Fact000013" name="dei:EntityFileNumber">001-41463</ix:nonNumeric></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span id="xdx_909_edei--EntityTaxIdentificationNumber_c20250814__20250814_zfVzXu30cqW2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2025-08-14" id="Fact000014" name="dei:EntityTaxIdentificationNumber">46-5211056</ix:nonNumeric></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction <br/>
    of incorporation)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission
    <br/>
    File Number)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer <br/>
    Identification Number)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span id="xdx_90E_edei--EntityAddressAddressLine1_c20250814__20250814_zB1aQ1fHi8b6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2025-08-14" id="Fact000015" name="dei:EntityAddressAddressLine1">3300
Nacogdoches Road</ix:nonNumeric></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, <span id="xdx_905_edei--EntityAddressAddressLine2_c20250814__20250814_zdmx3cncKkMc"><ix:nonNumeric contextRef="AsOf2025-08-14" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite
216</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span id="xdx_90E_edei--EntityAddressCityOrTown_c20250814__20250814_zEUvqRn7NH8c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2025-08-14" id="Fact000017" name="dei:EntityAddressCityOrTown">San
Antonio</ix:nonNumeric></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, <span id="xdx_909_edei--EntityAddressStateOrProvince_c20250814__20250814_zNWSwuCHiG84"><ix:nonNumeric contextRef="AsOf2025-08-14" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Texas</ix:nonNumeric></span></span></b><b>
<span id="xdx_900_edei--EntityAddressPostalZipCode_c20250814__20250814_zX14D1EqngFd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-08-14" id="Fact000019" name="dei:EntityAddressPostalZipCode">78217</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span id="xdx_907_edei--CityAreaCode_c20250814__20250814_zFiQL4U24bT9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2025-08-14" id="Fact000020" name="dei:CityAreaCode">(210)</ix:nonNumeric></b></span><b>
<span id="xdx_904_edei--LocalPhoneNumber_c20250814__20250814_zo8krI9NmJCk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-08-14" id="Fact000021" name="dei:LocalPhoneNumber">698-5334</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices and Registrant&#8217;s telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_90B_edei--WrittenCommunications_c20250814__20250814_zKyu4zwwjsjf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-08-14" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_edei--SolicitingMaterial_c20250814__20250814_zWtyy1OLCsf8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-08-14" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90F_edei--PreCommencementTenderOffer_c20250814__20250814_zaOfBz6E2sYa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-08-14" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90F_edei--PreCommencementIssuerTenderOffer_c20250814__20250814_zdju7V76ShZ6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-08-14" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_edei--Security12bTitle_c20250814__20250814__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue.007PerShareMember_zmycQC1KXd45" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2025-08-142025-08-14_custom_CommonStockParValue.007PerShareMember" id="Fact000026" name="dei:Security12bTitle">Common
    Stock, par value $.007 per share</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_edei--TradingSymbol_c20250814__20250814__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue.007PerShareMember_zaBgEVeQ5kId" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2025-08-142025-08-14_custom_CommonStockParValue.007PerShareMember" id="Fact000027" name="dei:TradingSymbol">BIAF</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90D_edei--SecurityExchangeName_c20250814__20250814__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue.007PerShareMember_zBbQuo3XWWRh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2025-08-142025-08-14_custom_CommonStockParValue.007PerShareMember" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_edei--Security12bTitle_c20250814__20250814__us-gaap--StatementClassOfStockAxis__custom--TradeableWarrantsToPurchaseCommonStockMember_zl2qyKVASB0f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2025-08-142025-08-14_custom_TradeableWarrantsToPurchaseCommonStockMember" id="Fact000029" name="dei:Security12bTitle">Tradeable
    Warrants to purchase Common Stock</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_edei--TradingSymbol_c20250814__20250814__us-gaap--StatementClassOfStockAxis__custom--TradeableWarrantsToPurchaseCommonStockMember_zFn1dODO6GC5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2025-08-142025-08-14_custom_TradeableWarrantsToPurchaseCommonStockMember" id="Fact000030" name="dei:TradingSymbol">BIAFW</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_edei--SecurityExchangeName_c20250814__20250814__us-gaap--StatementClassOfStockAxis__custom--TradeableWarrantsToPurchaseCommonStockMember_zmiqYKGNbrl3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2025-08-142025-08-14_custom_TradeableWarrantsToPurchaseCommonStockMember" format="ixt-sec:exchnameen" id="Fact000031" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90B_edei--EntityEmergingGrowthCompany_c20250814__20250814_zZ3GVONAmbDe"><ix:nonNumeric contextRef="AsOf2025-08-14" format="ixt:booleantrue" id="Fact000032" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_902_edei--EntityExTransitionPeriod_c20250814__20250814_zIwl3e8AfnKh"><ix:nonNumeric contextRef="AsOf2025-08-14" format="ixt:booleanfalse" id="Fact000033" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
2.02. Results of Operation and Financial Condition.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 14, 2025, bioAffinity Technologies, Inc., a Delaware corporation (the &#8220;Company&#8221;), issued a press release that included
financial information for its quarter ended June 30, 2025. A copy of the press release is attached as Exhibit 99.1 to this Current Report
on Form 8-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this Item 2.02 and in the press release attached as Exhibit 99.1 to this Current Report on Form 8-K shall not be deemed
to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this
Item 2.02 and in the press release attached as Exhibit 99.1 to this Current Report on Form 8-K shall not be incorporated by reference
into any filing with the U.S. Securities and Exchange Commission made by the Company, whether made before or after the date hereof, regardless
of any general incorporation language in such filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01. Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following exhibit is furnished with this Current Report on Form 8-K:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.75in; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.1in; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press
    Release issued by bioAffinity Technologies, Inc. dated August 14, 2025</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report on Form 8-K
to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    August 14, 2025</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BIOAFFINITY
                                            TECHNOLOGIES, INC.</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant)</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Maria Zannes</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maria
    Zannes</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1kU1uwjAQhU/AHUZRlwji0D9l10YUVYUqgoh2OyRDiUg80dihcKTesk5CWhatZcmy533vzcieN/Rm/JQXJPD+uJxDQmVVoCVY0paEdEpOET2/hODOJX3kxgpq2157MGLHkGNuRwrde6s85IayEPz7sboeBzeggnAygXjhDZp6xHqbZ6RtjgWgziAWriQni3LqHBI8suby1CatSUzOOgQ18rvyFwS+CuCVD/jJsjcwn0feYNiugTcTriunmh4t6YaEaUGlizMd/bvbbtLaWC7DRDAj3BT0htIMaRKOa0l3aMiNWLJeWU73Cyo3JI5SfhAo/+Hc0A8MPQ2WoTrz0BlA6/BH9IV/jLLGoqaR79/FJKsdCv2TeWk6hAoFDg0JVw0Llfsa09B93jdnrZWR -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 47%">&nbsp;<IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 125px; width: 300px"></TD>
  <TD STYLE="width: 5%">&nbsp;</TD>
  <TD STYLE="width: 48%">&nbsp;<IMG SRC="ex99-1_002.jpg" ALT="" STYLE="height: 84px; width: 400px"></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>bioAffinity
Technologies Reports Second Quarter 2025 Results</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>CyPath<SUP>&reg;</SUP>
Lung revenues up 62% year-over-year in first six months of 2025</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAN
ANTONIO, Texas (August 14, 2025) &ndash; <U>bioAffinity Technologies, Inc.</U> (Nasdaq: BIAF; BIAFW)</B>, a biotechnology company focused
on providing noninvasive, accurate detection of early-stage lung cancer and other lung diseases, today reported financial results for
the three months ended June 30, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Key
Highlights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increased
                                            CyPath<SUP>&reg;</SUP> Lung revenues 62% year-over-year for the six-month period ended June
                                            30, 2025.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Completed
                                            CyPath<SUP>&reg;</SUP> Lung tests in July represented a 72% increase over the previous monthly
                                            average for the first six months of 2025, including back-to-back record monthly sales in
                                            June and July.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Released
                                            real-world case studies demonstrating the diagnostic utility of CyPath<SUP>&reg;</SUP> Lung,
                                            including successful detection of Stage 1A lung cancers for multiple patients who had previous
                                            tests and imaging that incorrectly deemed the risk of cancer as low.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increased
                                            the list price of CyPath<SUP>&reg;</SUP> Lung to $2,900, aligning with private payer reimbursement
                                            strategies and enhancing per-test profitability.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expanded
                                            logistics capabilities through partnership with Cardinal Health&trade; OptiFreight<SUP>&reg;</SUP>
                                            Logistics, improving sample tracking, cost efficiency, and national delivery reliability
                                            in support of CyPath<SUP>&reg;</SUP> Lung&rsquo;s commercial growth.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Completed
                                            a $3.25 million public offering in May 2025 providing working capital.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointed
                                            Dr. Gordon Downie, MD, PhD, as Chief Medical Officer, bringing more than 30 years of clinical
                                            leadership in pulmonology and interventional lung care to support bioAffinity&rsquo;s diagnostic
                                            and clinical strategy.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Announced
                                            patent grants in the U.S., China, Canada, and Australia, expanding the Company&rsquo;s global
                                            intellectual property portfolio for both diagnostics and therapeutics, including a newly
                                            issued U.S. patent for a broad-spectrum cancer therapy targeting CD320 and LRP2 receptors.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Presented
                                            novel siRNA-based cancer therapy research at the 2025 RNA Therapeutics Conference, showcasing
                                            the potential of a new therapeutic approach to selectively kill cancer cells without harming
                                            healthy tissue.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">bioAffinity
                                            President and CEO Maria Zannes appointed to the American Lung Association in Texas Leadership
                                            Board, reinforcing the Company&rsquo;s advocacy and leadership in lung health and early cancer
                                            detection.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Management
Commentary</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Our
second quarter results reflect the continued acceleration of our CyPath<SUP>&reg;</SUP> Lung commercialization strategy, with testing
revenue up 62% for the first half of the year,&rdquo; Maria Zannes, President and Chief Executive Officer of bioAffinity Technologies
said. &ldquo;This growth is driven by increasing clinical adoption of our noninvasive lung cancer diagnostic and supported by physician-authored
case studies showing that CyPath<SUP>&reg;</SUP> Lung has identified early-stage cancers that other tests missed. These real-world results
are validating our test&rsquo;s unique value in guiding clinical decisions and improving patient outcomes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;The
success of our pilot marketing program in Texas, which has approximately 6% of the total number of U.S. pulmonologists, has demonstrated
that our approach to the medical community is sound and effective. We are prepared to meet increased demand as we implement our strategy
to enter additional key markets, including our expansion in the Mid-Atlantic region and the Veterans Administration healthcare system.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;During
the quarter, we took important steps to strengthen our financial foundation, including a successful $3.25 million public offering and
a strategic price adjustment for CyPath<SUP>&reg;</SUP> Lung to better reflect its value and align with reimbursement from private payers.
At the same time, our partnership with Cardinal Health OptiFreight&reg; Logistics has enhanced our national sample delivery capabilities
to meet growing demand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;We
are also proud to have expanded our leadership team with the appointment of Dr. Gordon Downie as Chief Medical Officer. His expertise
in pulmonary medicine and lung cancer screening is already shaping our clinical direction, including advancement toward pivotal trials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Our
intellectual property portfolio continues to grow with newly granted patents in the U.S., China, Canada, and Australia&mdash;strengthening
both our diagnostic and therapeutic platforms on a global scale. We also presented breakthrough research at the 2025 RNA Therapeutics
Conference, showcasing our siRNA-based approach to selectively kill cancer cells while sparing healthy tissue, a strategy with broad
potential across multiple tumor types.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Looking
ahead, we remain focused on expanding access to CyPath<SUP>&reg;</SUP> Lung, delivering operational efficiency, and advancing the next
generation of diagnostics and therapeutics,&rdquo; Zannes added. &ldquo;Every test we deliver is a step toward earlier cancer detection,
better patient care, and stronger value for our shareholders.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Second
Quarter 2025 Financial Results</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
for the quarter ended June 30, 2025, was $1.3 million, compared with $2.4 million for the second quarter of 2024. The decrease was primarily
attributable to the Company&rsquo;s strategic decision to discontinue unprofitable pathology services and reallocate resources toward
the commercialization of CyPath<SUP>&reg;</SUP> Lung. CyPath<SUP>&reg;</SUP> Lung testing revenue for the six months ended June 30, 2025,
increased approximately 62% year-over-year to $323,000, reflecting growth in physician adoption and an increase in total test results
delivered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
expenses for the second quarter of 2025 were $3.8 million, down 16% from $4.5 million in the second quarter of 2024. The decrease was
primarily due to lower direct costs related to laboratory operations and reduced research and development expenses, partially offset
by increased clinical development spending in support of the Company&rsquo;s pivotal trial strategy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Direct
                                            costs and expenses were $1.0 million, a 28% decrease from the prior-year period, driven by
                                            cost-saving initiatives implemented in March 2025.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
                                            and development expenses decreased 23% year-over-year to $311,000, reflecting lower compensation
                                            and lab supply costs.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
                                            development expenses increased to $129,000, up from $51,000 in Q2 2024, due to higher professional
                                            fees.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling,
                                            general and administrative expenses decreased 10% to $2.2 million, largely reflecting efficiencies
                                            following the integration of PPLS and adjustments to staffing and support functions.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
                                            and amortization expense declined 25% year-over-year to $113,000.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss for the quarter ended June 30, 2025, was $4.1 million, or $0.17 per share, compared with a net loss of $2.1 million, or $0.19 per
share, for the second quarter of 2024. The increase in net loss was primarily driven by a $1.5 million increase in non-cash expenses
related to warrant remeasurement and offering costs associated with the Company&rsquo;s May 2025 public offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents as of June 30, 2025, were $0.8 million, compared with $1.1 million as of December 31, 2024. bioAffinity Technologies
raised aggregate gross proceeds of $3.25 million through a public offering in May 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
bioAffinity Technologies, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">bioAffinity
Technologies, Inc. addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and broad-spectrum cancer
treatments. The Company&rsquo;s first product, <U>CyPath<SUP>&reg;</SUP> Lung</U>, is a noninvasive test that has shown high sensitivity,
specificity and accuracy for the detection of early-stage lung cancer. CyPath<SUP>&reg;</SUP> Lung is marketed as a Laboratory Developed
Test (LDT) by <U>Precision Pathology Laboratory Services</U>, a subsidiary of bioAffinity Technologies. For more information, visit <U>www.bioaffinitytech.com.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
statements in this press release constitute &ldquo;forward-looking statements&rdquo; within the meaning of the federal securities laws.
Words such as &ldquo;may,&rdquo; &ldquo;might,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;believe,&rdquo; &ldquo;expect,&rdquo;
&ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo; &ldquo;continue,&rdquo; &ldquo;predict,&rdquo; &ldquo;forecast,&rdquo; &ldquo;project,&rdquo;
&ldquo;plan,&rdquo; &ldquo;intend&rdquo; or similar expressions, or statements regarding intent, belief, or current expectations, are
forward-looking statements. These forward-looking statements are based upon current estimates and assumptions and include statements
regarding strategic actions reducing costs while expanding sales focus on high-margin diagnostics like CyPath<SUP>&reg;</SUP> Lung; international
patents expanding CyPath<SUP>&reg;</SUP> Lung&rsquo;s global commercialization potential; the targeted actions accelerating the commercial
growth of CyPath<SUP>&reg;</SUP> Lung; patient case studies continuing to underscore the diagnostic power of CyPath<SUP>&reg;</SUP> Lung
in real-world settings; expanding access to CyPath<SUP>&reg;</SUP> Lung for patients at risk of lung cancer; and advancing new diagnostics
for diseases like COPD and asthma. These forward-looking statements are subject to various risks and uncertainties, many of which are
difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth
or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations
include, among others, strategic actions reducing costs while expanding sales focus on high-margin diagnostics like CyPath<SUP>&reg;</SUP>
Lung; international patents expanding CyPath<SUP>&reg;</SUP> Lung&rsquo;s global commercialization potential; the targeted actions accelerating
the commercial growth of CyPath<SUP>&reg;</SUP> Lung; patient case studies continuing to underscore the diagnostic power of CyPath<SUP>&reg;</SUP>
Lung in real-world settings; expanding access to CyPath<SUP>&reg;</SUP> Lung for patients at risk of lung cancer; advancing new diagnostics
for diseases like COPD and asthma; and the other factors discussed in the Company&rsquo;s Annual Report on Form 10-K for the year ended
December 31, 2024, and its subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. Such forward-looking
statements are based on facts and conditions as they exist at the time such statements are made and predictions as to future facts and
conditions. While the Company believes these forward-looking statements are reasonable, readers of this press release are cautioned not
to place undue reliance on any forward-looking statements. The information in this release is provided only as of the date of this release,
and the Company does not undertake any obligation to update any forward-looking statement relating to matters discussed in this press
release, except as may be required by applicable securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contacts</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>bioAffinity
Technologies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Julie
Anne Overton</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
of Communications</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>jao@bioaffinitytech.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Relations </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dave
Gentry</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RedChip
Companies Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1-800-RED-CHIP
(733-2447)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Or
407-491-4498</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>BIAF@redchip.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>bioAffinity
Technologies, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Condensed
Consolidated Balance Sheets</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30, 2025</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31, 2024</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">(unaudited)</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">ASSETS</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left; padding-left: 10pt">Cash and cash equivalents</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">802,835</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">1,105,291</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Accounts and other receivables, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">421,869</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,139,204</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">Inventory</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">43,971</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27,608</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">400,151</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">422,995</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,668,826</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,695,098</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Non-current assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Property and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">351,368</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">375,385</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Operating lease right-of-use asset, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">399,879</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">463,011</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Finance lease right-of-use asset, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">167,730</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">780,872</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">Goodwill</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,404,486</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,404,486</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Intangible assets, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">745,972</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">775,139</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Other assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">12,814</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">19,676</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">4,751,075</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">6,513,667</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">LIABILITIES AND STOCKHOLDERS&rsquo; EQUITY (DEFICIT)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Current liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,169,837</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">987,311</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Accrued expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,048,034</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,398,722</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Unearned revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,404</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,404</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Operating lease liability, current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">133,239</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">127,498</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Finance lease liability, current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">179,844</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">395,301</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Notes payable, current portion</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">32,946</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">171,669</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Total current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,588,304</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,104,905</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Non-current liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Operating lease liability, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">274,074</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">342,098</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Finance lease liability, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,942</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">444,448</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Notes payable, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">45,952</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,180</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Warrant liability</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,974,911</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6,887,183</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,911,631</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Commitments and contingencies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Stockholders&rsquo; equity (deficit):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">Preferred stock, par value $0.001 per share; 20,000,000 shares authorized; no shares issued or outstanding at June 30, 2025, and December 31, 2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Common stock, par value $0.007 per share; 100,000,000 shares authorized; 28,459,541 and 15,576,674 issued and outstanding at June 30, 2025, and December 31, 2024, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">197,236</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">106,593</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">58,032,170</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">56,139,753</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(60,365,514</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(53,644,310</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total stockholders&rsquo; equity (deficit)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,136,108</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,602,036</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholders&rsquo; equity (deficit)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">4,751,075</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">6,513,667</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>bioAffinity
Technologies, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Unaudited
Consolidated Statements of Operations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1pt solid">Three Months Ended <BR> June 30,</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1pt solid">Six Months Ended <BR> June 30,</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2025</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2024</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2025</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2024</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; font-weight: bold; text-align: left">Net revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">1,269,483</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">2,397,652</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">3,123,080</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">4,804,043</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Operating expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Direct costs and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,016,602</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,407,710</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,384,462</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,981,151</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Research and development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">311,372</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">402,433</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">678,758</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">796,072</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Clinical development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">129,279</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">51,462</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">267,632</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100,422</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Selling, general and administrative</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,214,561</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,472,775</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,667,110</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,658,719</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Depreciation and amortization</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">113,229</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">151,070</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">267,817</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">300,707</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,785,043</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,485,450</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,265,779</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,837,071</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Loss from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,515,560</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,087,798</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,142,699</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,033,028</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other income (expense):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,025</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,186</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,567</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,313</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(10,460</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(22,249</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(25,945</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(45,799</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Other income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,053</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,055</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,511</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Other expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(483,043</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(492,685</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Change in fair value of warrants issued</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,062,818</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,062,818</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total other income (expense), net</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,516,243</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(17,062</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,540,826</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(29,975</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Net loss before provision for income tax expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,031,803</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,104,860</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,683,525</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,063,003</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Income tax expense</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">28,984</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,419</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">37,679</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9,091</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(4,060,787</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(2,110,279</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(6,721,204</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(4,072,094</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Net loss per common share, basic and diluted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.17</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.19</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.20</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.38</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Weighted average common shares outstanding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,021,546</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,389,308</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,148,211</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,655,483</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "D 8L# 2(  A$! Q$!_\0
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MU[^RSX@^(_BB/Q?X2C2_NW@6"\T]I%C=B@PKH6(!^7 ()'W1C.3@8D+^R_\
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M>"48 9P<@JIYQ@_ O_!+;P_KMY\?;W5K&.9=$L]*FCU"89$9WE?+C)Z%BP#
M>B$]J_6.@#\\_@[_ ,$PM6T3QM9:EXZ\0:7=Z+93+-]ATHR.]UM.0KLZ*$4X
M&<9.,CCK7Z%@   # ':EHH$%%%% !1110 4444 %%%% !1110 4444 %%%%
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MR(/9!0!]=T45F>)_$-EX1\.:IKFI2B'3]-M9;RXD/\,<:EF/Y TA'S;\>?\
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M_HVD(^5_^"3>H21?&OQ99 GR9] :5AGC<EQ"!_Z&U?JA7Y2_\$H/^2^^)/\
ML6YO_2FVK]6J;&S\<?\ @I/_ ,G7^(/^O*R_])TK]'/V(/\ DU/X=?\ 7@__
M *.DK\X_^"D__)U_B#_KRLO_ $G2OT<_8@_Y-3^'7_7@_P#Z.DH>P/8]RK\?
M/^"FG_)TVH_]@RS_ /0#7[!U^/G_  4T_P"3IM1_[!EG_P"@&A C]!?V#/\
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MPQW\PE/^V8H0(]1_X)3_  A_MGQMX@^(E[!NMM&A_L^P9AP;B49D8>ZQ\?\
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M$[]E#_DY?X:?]A^T_P#1JU^[%?A/^RA_R<O\-/\ L/VG_HU:_=BFQL*^5_\
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M4GNV[O[S[&JCJFAZ;KD<::EI]KJ"1G<BW4*RA3Z@,#BOG#Q'XT^-'PA_9?\
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M9_A;X;U**^UK4G3^UY+60,MI;J0WE,1_&[!<KV4'/WA0!\)&/5/VF?VAG%M
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MV[FF,A_;7C\0KX5_9]L_B)-8W%P_B6+^WY+ $6;/N0?+N .-C2=1ZU]V  #
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M2,8W$GD(#UZFM'_@H6)S^S=\)!:E%NCK6G^49/NA_L<N,^V:E^(W[*OQ6?\
M93\'?!O08- U46Y>YU749+MX?+E%PTL:1!A\RX<@DCMVKI/C]\"_BQ\:OV>_
M 6B/I>AV?C'0]8BNI[6*]/V;R8HI8T(<C))W(2/<T =G\.=+_:A@\;Z3)XUU
MCP)<>%EE)OXM,2;[2T>T_<S&!G..]97QU_95\47OQ+E^+'P?\4#PKX]>)8[V
MTN0#::DJ@ !^" 2%4$,"IV@_*1FM32?$_P"U))JMDFH^#? $6GM.@N9(;^<N
ML6X;ROS]<9Q5'QSJ_P"TWX%^(WB";PKX>T#Q]X+O+@3:?;W5VD%S:*54%-Q9
M. VXX.[V(Z4 6/V</VI=<\<>-]1^&/Q-\-_\(E\2M-A\_P J('[-?1 #+Q\G
M!P0V S C)!X('TK7RO\ !+X'?$G7_CY<_&;XL_V7I&L1:>=-TS0=(?S%@C((
MW.^2. S\;F)+$\  5]44A!1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% 'Y/?M-?L\?''4?CWXZU7PQX9\0RZ'JFHR3P3:;*?*F0@<D*WZ&I
M/@/_ ,$S_'?C/7+:_P#B(G_")>'T??/;F99+ZX&?NJ%)"9_O,<C/W37ZNT4[
MCN9/A3PKI7@CPYIV@Z'8Q:;I&GPK!;6L(PL:#^9[DGDDDGDUK444A!1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
, !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_002.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #+ \P# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKE_B9XXC^&_@C4O$<EHU^E
MEY>;=)-A??*D?7!QC?GIVH ZBBOF#_AN*Q_Z%&X_\#E_^(H_X;BL?^A1N/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR: /M_\ X:\^'G_/SJ'_ (!G_&O1O /C_2OB3H1U?1O/-EYS0AKB(QEF4#)
M].<9]0:_-$ L0 "2> !7Z3?"GPD/ WPZT'12FR:VM5,X_P"FK?/)_P"/,U '
M64R65((GDD=8XT!9G8X"@=23V%)<3QVL$DTTBQ0QJ7=W. J@9))],5\)?'?]
MH#4OB9JD^G:;/+9>&(6*1P(Q4W6#_K)/7/4+T''?F@#Z8\6?M0> /"D[P?VG
M)K%PF=R:5'YP'_ R0A_!JX&\_;>T9'(M?#%],N>LUPD9Q] &KY#HH ^M5_;A
ML"PW>$KD+GDB]4G_ - KI]!_;'\#ZI*D=_!J>CL<;I)X!)&/Q1BW_CM?$=%
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KRK]J/_ )(5XF_[=?\
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M]X9UN7PUXCTO5H<^;8W45RH'<HP;'Z5^GEK=17MK#<0N)(9D$B..C*1D'\J
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M%"JHP%48 %.H **** "BBB@ HHHH _-'XF_\E)\6?]A:[_\ 1SUS5=+\3?\
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M]\-PZ3\*O[3"#[1JMU)(\G<I&3&J_0%7/_ C0!K>&OV6?A]H%E''<:4VLW(
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MPP(Y\N0= V/P(Y'0@?H)7G/[0GAJ'Q/\'_$D4B!I+2V:^B8]4:(;\CZJ&'_
MC0!^>5?4/[&?Q(F2^O?!=Y-NMG1KNP#'[C@_O$'L0=V/]ECWKY>KJ/A=K[^%
M_B-X;U-)#&(+^+S"#UC+!7'XJ6'XT ?I77B7[6>MZM9?#==,TFSO+AM3F\NY
MEMH6=8X%Y8,P'R[CM'/4;O>O;:* /RM92C%6!5@<$'J*ZSX7_#F_^*7B^VT.
MP980P,MQ<.,B&($;GQWZ@ =R1TZU^B.L>%=%\0J1JFD6&I ]?M=LDO\ Z$#5
M#PO\./#/@J]N[O0M&MM,N+I0LS6ZD;@"2 !G &3VQV]!0!Q'A[]EGX>:':1Q
MS:0^K7"_>N;Z=V9C_NJ0O_COYU+K'[+_ ,.-7MY$70382MG$]G<R(R$]P"Q7
M\P17JU<AXD^+O@SPDK_VIXDT^"1/O0I,)91_VS3+?I0!\&_%OX<7'PL\;7>A
MS2FX@ $UK<$8,L+9VDCL<@@^ZGM7&UZW^TG\3=#^*/C&QO\ 0TN##:VGV5YK
MB,)YF'9@5&<X^8]<'VKR2@#ZL_8?UAS%XKTIC^[5H+E!Z$[U;^2?E7U/7Q[^
MQ&Y'C#Q&G8V"'\I!_C7V%0!\0_MB>(YM5^*::66Q;Z7:1HB9XWR#S&;ZD%!_
MP$5X57MG[7FARZ9\8+B]>,K%J5K#.C]FVKY9_$;!^8KQ.@#ZA_9?^!/AKQ=X
M7?Q-K\ U61[AX8+1V(BB"XR6 /S$D]#QC''-?1EM\,/!]I!Y,/A718X^ZC3X
MN?K\O-? _P ./C#XG^%D\AT.]46LS!YK*X3S(9#ZD=0?=2#QUKZ \+_MMV,H
M2/Q%X=GMVZ-/ILHD!/KL?:0/^!&@#TWQI^S?X%\7V$L4>BV^BW>T^5=Z9&(2
MC8X)1<*PZ<$?B*^&_''@R_\  7BS4/#^H -=VD@3?'G;(I *LOL00?QK[L\-
M_M%_#WQ,42#Q%!9S-_RRU -;D'TW. I_ FN[M8--OIEU.VCM;B61<+>1*K,R
M^@<=1^- 'YQZ)\+?&'B/:=.\,ZI<QMR)1:NL9_X&0%_6ON+]G[2_$V@?#6QT
MKQ39-97MDS10!Y4D+0<%,E2<8R5QV"BO2** "OE3]LOXE2I+8^#+&<K&4%WJ
M 0_>Y_=1G\BQ'NA[5]5U^:_Q7\1?\)9\2?$FJAM\<][((F'>-3M3_P =5: .
M4KL_A3\+=4^+'B9=+T\B""-1)=7D@RD$><9QW8]E[^P!(XRON#]CWPW#I/PJ
M_M,(/M&JW4DCR=RD9,:K] 5<_P# C0!K>&OV6?A]H%E''<:4VLW( WW-],Q+
M'_=4A0/P_$UA_$#]D3PIKVGROX<1O#^J*N8\2/);R'T=6)(SZJ>.N#7O-% '
MY>>(-!OO"^M7FDZG;M:WUI(8I8F[$>GJ",$'N"#52UNIK&ZAN;>5H;B%Q)'*
MAPR,#D$'L017T3^VOX:AT_Q=H6M1($?4;9X9<?Q-$5PQ]]LBC_@(KYQH _1O
MX,>/O^%D_#K2M:E*_;64PW:H, 3(<-QVSPV/1A7<5\I_L0:^_F>*-$>0F/$-
MY%'G@'E'/X_N_P J^K* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR
MK]J/_DA7B;_MU_\ 2J*O5:\J_:C_ .2%>)O^W7_TJBH ^ :Z#X>_\C]X:_["
M=M_Z-6N?KH/A[_R/WAK_ +"=M_Z-6@#],Z\F_:.^$X^)O@AY+.+?KNF!I[/:
M/FD&/GB_X$ ,>X'O7K-% 'Y6D%20001P0: 2""#@CN*]Y_:O^$W_  AWBD>)
M-.AVZ/J\A,JH/E@N>K#Z/RP]]WH*\%H ^C?%7Q8'Q*_9DFM[V8-KNEWEM!=;
MC\TJY.R7\0"#[@^HKYRJ2.>2*.1$D94E 5U!P& ((!]>0#^%1T =K\%/^2N>
M$/\ L)P?^ABOT>K\X?@I_P E<\(?]A.#_P!#%?H]0!\]?MK77E_#C1K<'!EU
M57_!8I?_ (H5\8U]I?MIV33_  RTNX52WD:K'N([*T4HS^>T?C7Q;0!+:7<]
MA=0W5K-);7,+K)%-"Y5XW!R&4CD$$ @BNE_X6QXW_P"AR\0?^#2?_P"+JAX(
M\/Q>+/&&C:+-<&TCU"[CM3.J[BF]@H.,C/)KZ9_X8=L?^ANN/_ %?_BZ /G7
M_A;'C?\ Z'+Q!_X-)_\ XNC_ (6QXW_Z'+Q!_P"#2?\ ^+KZ*_X8=L?^ANN/
M_ %?_BZ/^&';'_H;KC_P!7_XN@#Y1O+RXU&[FNKN>2ZNIG,DLTSEWD8G)9F/
M))/<U#7UI_PP[8_]#=<?^ *__%T?\,.V/_0W7'_@"O\ \70!W_[)]TUQ\%-)
M1FW"&>XC'/0>:S8_\>KV"N,^$WPX3X5^$4T*._;4D6=YA,\0C/S8XP"?2NSH
M _/;]HGPC_PAWQ<URW1-EM>2?;H,# VR_,<>P?>/PKS6OK7]MGPCY^F:#XFB
M3YH)&L)V'7:P+QY]@5?_ +Z%?)5 'Z!_LU^*?^$J^#VAN[[[BQ4V$OL8SA?_
M !S8?QKXJ^+?B;_A,/B7XCU8/YD4]XZPMZQ)\D?_ (ZJUZ3^SU\3_P#A"_ G
MQ$LWEV/'8?;K,9QB4_N?U9X?RKPB@#3\,:'+XF\2:7I$&?-OKJ.V4CL78+G\
M,YKW#]LCP=%H/B[0M2M81%:7=B+;:HX#0G _\<9!_P !K#_9+\,?V_\ %VUN
MW3?!I5O)=MGINQL3\<OG_@->^?M>^&/[;^%#:@B;IM)NH[C(Z^6W[MA^;*?^
M T ?#E?H3^SMXG_X2;X.>'[B1P9K2$V4I)Z>42BY_P" !3^-?GM7N_P9^)W_
M  B?P4^(VGF79<(B268SSOG'DL1_NX1J /+OB9XI/C7Q_KVM;B\=W=NT1/\
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MX_\  %?_ (N@#Y+I02""#@CN*^L_^&';'_H;KC_P!7_XNC_AAVQ_Z&ZX_P#
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MK[1HFK7>F2YR?LTI56_WEZ-]"#535M!U/0+CR-3TZ[TZ?_GG=P-$WY, :HT
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M/]0H!J_110 4444 %%%% 'YH_$W_ )*3XL_["UW_ .CGKFJZ7XF_\E)\6?\
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M<  #J2>U 'Z*?#+XS>'_ (LB\_L1;U7M%5IENH-FS=G:,@D9.#QGM7=UYM\
MOAA_PJ[P!;V=PH_M:\/VJ^8<[7(&(\^BC ],[CWKTF@ HHHH **** "BBB@
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M$V:5I-CIBXP19VZ19_[Y H ^1/A'^R9K/B*Y@U'Q=&^C:2#N^Q$XNIQZ$?\
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MX_+U'3[74(\8V74"R#\F!KE;GX(> ;H'?X1TE<G=^[ME3_T''Y4 ?G)5_1-
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M1QV'<^W6UK#9PK#;PQP0KPL<:A5'T J6@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
'"BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>biaf-20250814.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaSE6bP9z5Z8yekhvWBwbckK7yEs+zipuCQrACNm0XoD -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:BIAF="http://bioaffinitytech.com/20250814" elementFormDefault="qualified" targetNamespace="http://bioaffinitytech.com/20250814">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://bioaffinitytech.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="biaf-20250814_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="biaf-20250814_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="biaf-20250814_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="BIAF_CommonStockParValue.007PerShareMember" name="CommonStockParValue.007PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BIAF_TradeableWarrantsToPurchaseCommonStockMember" name="TradeableWarrantsToPurchaseCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>biaf-20250814_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="biaf-20250814.xsd#Cover" roleURI="http://bioaffinitytech.com/role/Cover" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bioaffinitytech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="biaf-20250814.xsd#BIAF_CommonStockParValue.007PerShareMember" xlink:label="loc_BIAFCommonStockParValue.007PerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BIAFCommonStockParValue.007PerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="biaf-20250814.xsd#BIAF_TradeableWarrantsToPurchaseCommonStockMember" xlink:label="loc_BIAFTradeableWarrantsToPurchaseCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BIAFTradeableWarrantsToPurchaseCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>biaf-20250814_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="biaf-20250814.xsd#BIAF_CommonStockParValue.007PerShareMember" xlink:label="BIAF_CommonStockParValue.007PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BIAF_CommonStockParValue.007PerShareMember" xlink:to="BIAF_CommonStockParValue.007PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BIAF_CommonStockParValue.007PerShareMember_lbl" xml:lang="en-US">Common Stock, par value $.007 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="biaf-20250814.xsd#BIAF_TradeableWarrantsToPurchaseCommonStockMember" xlink:label="BIAF_TradeableWarrantsToPurchaseCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BIAF_TradeableWarrantsToPurchaseCommonStockMember" xlink:to="BIAF_TradeableWarrantsToPurchaseCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BIAF_TradeableWarrantsToPurchaseCommonStockMember_lbl" xml:lang="en-US">Tradeable Warrants to purchase Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>biaf-20250814_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="biaf-20250814.xsd#Cover" roleURI="http://bioaffinitytech.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://bioaffinitytech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="biaf-20250814.xsd#BIAF_CommonStockParValue.007PerShareMember" xlink:label="loc_BIAFCommonStockParValue.007PerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BIAFCommonStockParValue.007PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="biaf-20250814.xsd#BIAF_TradeableWarrantsToPurchaseCommonStockMember" xlink:label="loc_BIAFTradeableWarrantsToPurchaseCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BIAFTradeableWarrantsToPurchaseCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 14, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 14,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BIOAFFINITY
TECHNOLOGIES, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001712762<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-5211056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3300
Nacogdoches Road<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite
216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San
Antonio<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">78217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(210)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">698-5334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=BIAF_CommonStockParValue.007PerShareMember', window );">Common Stock, par value $.007 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $.007 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BIAF<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=BIAF_TradeableWarrantsToPurchaseCommonStockMember', window );">Tradeable Warrants to purchase Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Tradeable
    Warrants to purchase Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BIAFW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=BIAF_CommonStockParValue.007PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=BIAF_CommonStockParValue.007PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=BIAF_TradeableWarrantsToPurchaseCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=BIAF_TradeableWarrantsToPurchaseCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bioaffinitytech.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>biaf-20250814.xsd</File>
    <File>biaf-20250814_def.xml</File>
    <File>biaf-20250814_lab.xml</File>
    <File>biaf-20250814_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "BIAF",
   "nsuri": "http://bioaffinitytech.com/20250814",
   "dts": {
    "schema": {
     "local": [
      "biaf-20250814.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "biaf-20250814_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "biaf-20250814_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "biaf-20250814_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 65,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 27
   },
   "report": {
    "R1": {
     "role": "http://bioaffinitytech.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-08-14",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-08-14",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "auth_ref": []
    },
    "BIAF_CommonStockParValue.007PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bioaffinitytech.com/20250814",
     "localname": "CommonStockParValue.007PerShareMember",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, par value $.007 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "BIAF_TradeableWarrantsToPurchaseCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bioaffinitytech.com/20250814",
     "localname": "TradeableWarrantsToPurchaseCommonStockMember",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tradeable Warrants to purchase Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001641172-25-024036-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001641172-25-024036-xbrl.zip
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M(W3:'0($B2!4CW()TH0&C&]8Y7&'2[85'>#S)0OA&4I'E%VH>E6ACE9KB$>
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M7U_<)I"F649)EA/#7-YV/IV6M&)/QI5*,BS)<)7V%38F3:K9YE>]6!=0-XT
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M42V/J!4O,652?!(!=E*1ZP4@346"^H<Q4\<$T8IEC9QC$PP_V^H8)W#B^V#
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MA,A'VN;/)43V/"%R8O)7.]G[[CRSF]G19K/;772AQLWN[GVN)EF_\$<5)J$
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M[-PO7,.G^QJ]/U93\JTLVT?XO+)5;57+5^G=CM"WZ\>X==C$@I;&Q[1Q?G1
MSD^WTI6QD3ZH9]O=?ME(_?-#$<KYXY.?TKG1,>^%7:V<2^W^*-3/4E='1_O&
M#6YM%5)[!X>66KF5.N3\.@?#]JH]X>#L3CC2NA86"KN%])6JF[_/6^[NI&1#
M';-_^_9 *_T?4$L! A0#%     @ ^($.6],GEFS1 P  YPX  !$
M     ( !     &)I868M,C R-3 X,30N>'-D4$L! A0#%     @ ^($.6W%@
M6&4$"0  D6@  !4              ( !  0  &)I868M,C R-3 X,31?9&5F
M+GAM;%!+ 0(4 Q0    ( /B!#EML$ "9\0L   R0   5              "
M 3<-  !B:6%F+3(P,C4P.#$T7VQA8BYX;6Q02P$"% ,4    " #X@0Y;JBHW
M4%((   K8P  %0              @ %;&0  8FEA9BTR,#(U,#@Q-%]P<F4N
M>&UL4$L! A0#%     @ ^($.6S/*:A-3(0  OFX!  H              ( !
MX"$  &5X.3DM,2YH=&U02P$"% ,4    " #X@0Y; ?)$<O 4   9HP  "P
M            @ %;0P  9F]R;3@M:RYH=&U02P4&      8 !@!Y 0  =%@
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:BIAF="http://bioaffinitytech.com/20250814"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="biaf-20250814.xsd" xlink:type="simple"/>
    <context id="AsOf2025-08-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001712762</identifier>
        </entity>
        <period>
            <startDate>2025-08-14</startDate>
            <endDate>2025-08-14</endDate>
        </period>
    </context>
    <context id="From2025-08-142025-08-14_custom_CommonStockParValue.007PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001712762</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BIAF:CommonStockParValue.007PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-14</startDate>
            <endDate>2025-08-14</endDate>
        </period>
    </context>
    <context id="From2025-08-142025-08-14_custom_TradeableWarrantsToPurchaseCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001712762</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BIAF:TradeableWarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-14</startDate>
            <endDate>2025-08-14</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-08-14" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-08-14" id="Fact000004">0001712762</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-08-14" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-08-14" id="Fact000010">2025-08-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-08-14" id="Fact000011">BIOAFFINITY TECHNOLOGIES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-08-14" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-08-14" id="Fact000013">001-41463</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-08-14" id="Fact000014">46-5211056</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-08-14" id="Fact000015">3300 Nacogdoches Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-08-14" id="Fact000016">Suite 216</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-08-14" id="Fact000017">San Antonio</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-08-14" id="Fact000018">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-08-14" id="Fact000019">78217</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-08-14" id="Fact000020">(210)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-08-14" id="Fact000021">698-5334</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-08-14" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-08-14" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-08-14" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-08-14" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2025-08-142025-08-14_custom_CommonStockParValue.007PerShareMember"
      id="Fact000026">Common     Stock, par value $.007 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-08-142025-08-14_custom_CommonStockParValue.007PerShareMember"
      id="Fact000027">BIAF</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-08-142025-08-14_custom_CommonStockParValue.007PerShareMember"
      id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-08-142025-08-14_custom_TradeableWarrantsToPurchaseCommonStockMember"
      id="Fact000029">Tradeable     Warrants to purchase Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-08-142025-08-14_custom_TradeableWarrantsToPurchaseCommonStockMember"
      id="Fact000030">BIAFW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-08-142025-08-14_custom_TradeableWarrantsToPurchaseCommonStockMember"
      id="Fact000031">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-08-14" id="Fact000032">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-08-14" id="Fact000033">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
